🇺🇸 FDA
Patent

US 12404347

Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof

granted A61KA61K2039/505A61K2239/17

Quick answer

US patent 12404347 (Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof) held by The Board of Regents of the University of Texas System expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2239/17, A61K2239/31, A61K2239/38